Testosterone Propionate: Clinical Trials

12 trials of Testosterone Propionate, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

5 completed, 2 recruiting, 2 unknown, 1 active not recruiting. 12 Phase 2, 3 Phase 3, 1 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 212Completed 5, Recruiting 2, Unknown 2, Active not recruiting 1, Not yet recruiting 1, Suspended 1
Phase 33Completed 1, Not yet recruiting 1, Unknown 1
Phase 11Suspended 1

Follow Testosterone Propionate: new trials by email Literature Review of Testosterone Propionate trials Research Report on Testosterone Propionate

Trials (filtered) newest first · largest first

All 12 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Testing the Use of High Dose Testosterone Followed by Darolutamide Compared to the Usual Care for Patients With Metastatic Prostate Cancer
Abiraterone Acetate, Biospecimen Collection, Bone Scan - Metastatic Castration-Resistant Prostate Adenocarcinoma, Stage IVB Prostate Cancer AJCC v8
Phase 2 / Phase 3Not yet recruitingECOG-ACRIN Cancer Research Group4322027-01-062026-10-01
Supraphysiological Androgen to Enhance Treatment Activity in Metastatic Castration-Resistant Prostate Cancer, SPECTRA Study
Biopsy Procedure, Biospecimen Collection, Bone Scan - Castration-Resistant Prostate Carcinoma, Metastatic Prostate Adenocarcinoma
Phase 2RecruitingUniversity of Washington692024-05-212026-07-21
Testosterone Treatment in Men With Chronic Kidney Disease
Jatenzo Pill - Hypogonadism, Male, Kidney Disease, Chronic
Phase 2RecruitingSt. Louis University202022-03-152026-04-30
Safety and Efficacy of Oral Testosterone Undecanoate Followed by Enzalutamide as Therapy for Men With Metastatic Castrate Resistant Prostate Cancer
Testosterone Undecanoate, Enzalutamide - Prostate Cancer, Castration-resistant Prostate Cancer
Phase 2Active not recruitingSidney Kimmel Comprehensive Cancer Center at Johns Hopkins152022-03-072026-09-29
Use of Testosterone to Prevent Post-Surgical Muscle Loss - Pilot Study
Aveed 750 MG in 3 ML IM Injection, Normal Saline 3 ML IM Injection - Muscle Atrophy, Surgery
Phase 2 / Phase 3UnknownThe Stone Research Foundation for Sports Medicine and Arthritis152020-05-082021-08-31
COMbination of Bipolar Androgen Therapy and Nivolumab
Testosterone cypionate, Nivolumab - Castration-resistant Prostate Cancer, Metastatic Prostate Cancer
Phase 2CompletedSidney Kimmel Comprehensive Cancer Center at Johns Hopkins452018-09-052024-02-20
Testosterone and Olaparib in Treating Patients With Castration-Resistant Prostate Cancer
Laboratory Biomarker Analysis, Olaparib, Quality-of-Life Assessment - Castration-Resistant Prostate Carcinoma, Prostate Adenocarcinoma
Phase 2CompletedUniversity of Washington362018-08-292025-09-29
A Study of Ejaculatory Dysfunction in Men With Low Testosterone Levels
Testosterone Solution 2%, Placebo Solution - Ejaculatory Dysfunction, Hypogonadism
Phase 2CompletedEli Lilly and Company762011-08-012014-12-19
A Study of the Pharmacokinetics of Testosterone Metered Dose (MD)-Lotion Formulations
Testosterone MD-Lotion - Hypogonadism
Phase 2CompletedEli Lilly and Company212007-10-012011-01-07
Vaginal Testosterone Cream For Atrophic Vaginitis in Women Taking Aromatase Inhibitors for Breast Cancer.
Testosterone propionate - Vaginitis, Dyspareunia
Phase 1 / Phase 2SuspendedUniversity of Vermont302006-12-012010-05-13
Deslorelin Combined With Low-Dose Add-Back Estradiol and Testosterone in Preventing Breast Cancer in Premenopausal Women Who Are at High Risk for This Disease
therapeutic estradiol, deslorelin, therapeutic testosterone - brca1 Mutation Carrier, brca2 Mutation Carrier
Phase 2UnknownCity of Hope Medical Center112004-03-112024-08-28
Testosterone Replacement Therapy in Chronic Spinal Cord Injury
Testosterone Transdermal System (Androderm 5 mg patch) - Spinal Cord Injury, Hypogonadism
Phase 2 / Phase 3CompletedVA Office of Research and Development312003-08-012017-11-01

Conditions studied

Prostatic Neoplasms (4)  ·  Hypogonadism (3)  ·  Breast Neoplasms (2)  ·  Disease (1)  ·  Dyspareunia (1)  ·  Ejaculatory Dysfunction (1)  ·  Erectile Dysfunction (1)  ·  Eunuchism (1)  ·  Knee Injuries (1)  ·  Muscular Atrophy (1)  ·  Renal Insufficiency, Chronic (1)  ·  Sexual Dysfunction, Physiological (1)  ·  Sexual Dysfunctions, Psychological (1)  ·  Spinal Cord Injuries (1)  ·  Vaginitis (1)

Sponsors

Eli Lilly and Company (2)  ·  Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins (2)  ·  University of Washington (2)  ·  City of Hope Medical Center (1)  ·  ECOG-ACRIN Cancer Research Group (1)  ·  St. Louis University (1)  ·  The Stone Research Foundation for Sports Medicine and Arthritis (1)  ·  University of Vermont (1)  ·  VA Office of Research and Development (1)

Countries

United States (11)  ·  Canada (1)

Top investigators

Michael Schweizer (2)  ·  Hyman Muss, MD (1)  ·  Jeffrey Weitzel, MD (1)  ·  Mani Vessal, Ph.D. (1)  ·  Marie Wood, MD (1)  ·  Mark Markowski, MD, Ph.D (1)  ·  Michael T. Schweizer (1)  ·  Sabrina M Witherby, MD (1)  ·  Samuel Denmeade, MD (1)  ·  Sandeep Dhindsa, MD (1)  ·  William Bauman, MD (1)

Results publications

PMID 21252493, PMID 21717386, PMID 23343764, PMID 24968251, PMID 26158605, PMID 38167882, PMID 38224135

NIH funding

P30CA015704 (1), P30CA033572 (1), P50CA097186 (1), U10CA180820 (1)